Invention Grant
- Patent Title: Compound for treating oxidative stress in canines
-
Application No.: US17207339Application Date: 2021-03-19
-
Publication No.: US11596663B2Publication Date: 2023-03-07
- Inventor: Winifred Jean Dodds
- Applicant: HEMOPET
- Applicant Address: US CA Garden Grove
- Assignee: HEMOPET
- Current Assignee: HEMOPET
- Current Assignee Address: US CA Garden Grove
- Agency: Greenberg Traurig, LLP
- Main IPC: A61K36/49
- IPC: A61K36/49 ; A61K31/198 ; A61K31/353 ; A61K31/355 ; A61K31/375 ; A61K33/30

Abstract:
Managing and treating elevated OS biomarkers in mammals such as companion animals with at least one of the supplements alpha-lipoic acid, carnitine, co-enzyme Q-10, ginger, green tea, licorice, milk thistle, garlic, honey. resveratrol, soybeans, tomatoes, turmeric, vitamin D, vitamin E, or selenium. Other compounds are Zinc, Vitamin E, Vitamin C, Quercetin, L-glutamine and Robuvit. Diagnosing an oxidative stress (OS) in a mammal detects an OS biomarker, selectively isoprostane and other antioxidant biomarkers such as HODE, microRNAs, TAC, GSH, MDA, and TNF-alpha. The sample can be saliva.
Public/Granted literature
- US20210205390A1 COMPOUND FOR TREATING OXIDATIVE STRESS IN CANINES Public/Granted day:2021-07-08
Information query